Wojcicki last spring first offered to buy the company and take it public. Anne Wojcicki, the CEO of pioneering genetic testing company 23andMe, is open again to a third-party takeover of the company.

CEO Anne Wojcicki last spring proposed buying out the company and taking it private. Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said ...

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final ...

23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an earnings call in February last year. She said the biotech company, which offers direct-to-consumer genetic testing ...

23andMe CEO Anne Wojcicki. Photographer: Kyle Grillot/Bloomberg via Getty Images Related: 'Surprised and Disappointed': All Independent Board Members of 23andMe Resign, Leaving Only the CEO ...

CEO Anne Wojcicki noted at the time that the action was required to concentrate on the long-term viability of the consumer side of the firm and research collaborations. For its internal medicines ...

months after co-founder and CEO Anne Wojcicki's buyout plan started a fight with her onetime board. The Sunnyvale, California-based company (Nasdaq: ME) said dwindling cash, a potential legal ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations.